RB-164
Phase 1- Indications
- Hematologic malignancies, Solid tumors
Company intelligence / Profile preview
Radiance Biopharma
New York City, New York, United Statesradiancebio.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Radiance Biopharma is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates with improved safety profiles. Its lead program RB‑164™ targets ROR‑1 and is in Phase 1 trials for hematologic cancers and solid tumors. Preclinical data suggest favorable toxicity and efficacy. Additional pipeline assets include a bispecific HER2/TROP2 ADC in preclinical development.
- Therapeutic areas
- OncologyHematology
- Modalities
- Antibody-drug conjugateBispecific monoclonal antibody (for bispecific ADCs)Monoclonal antibody (for RB-203)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
CSPC Megalith Biopharmaceutical Co., Ltd / CSPC Pharmaceutical Group Limited – exclusive license for ROR‑1 targeted ADC in major Western marketsBiocytogen – bispecific ADC agreement
Beyond the preview
Go deeper on Radiance Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Radiance Biopharma.